SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-20-016138
Filing Date
2020-06-29
Accepted
2020-06-29 16:01:29
Documents
74
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0320_yewbiopharm.htm 10-Q 652416
2 CERTIFICATION f10q0320ex31-1_yewbio.htm EX-31.1 9865
3 CERTIFICATION f10q0320ex31-2_yewbio.htm EX-31.2 9698
4 CERTIFICATION f10q0320ex32_yewbio.htm EX-32 4674
  Complete submission text file 0001213900-20-016138.txt   4340678

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE yewb-20200331.xml EX-101.INS 704518
6 XBRL SCHEMA FILE yewb-20200331.xsd EX-101.SCH 88556
7 XBRL CALCULATION FILE yewb-20200331_cal.xml EX-101.CAL 63993
8 XBRL DEFINITION FILE yewb-20200331_def.xml EX-101.DEF 194399
9 XBRL LABEL FILE yewb-20200331_lab.xml EX-101.LAB 461799
10 XBRL PRESENTATION FILE yewb-20200331_pre.xml EX-101.PRE 314150
Mailing Address 9460 TELSTAR AVENUE, SUITE 6 EL MONTE CA 91731
Business Address 9460 TELSTAR AVENUE, SUITE 6 EL MONTE CA 91731 626-401-9588
Yew Bio-Pharm Group, Inc. (Filer) CIK: 0001548240 (see all company filings)

IRS No.: 261579105 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54701 | Film No.: 20997465
SIC: 0100 Agricultural Production-Crops